# HybridAPC for Gastric Mucosal Ablation in Obese Patients.

> **NCT05587491** · NA · COMPLETED · sponsor: **Erbe Elektromedizin GmbH** · enrollment: 15 (actual)

## Conditions studied

- Obesity
- Adiposity

## Interventions

- **DEVICE:** Hybrid Argonplasma coagulation (HAPC)

## Key facts

- **NCT ID:** NCT05587491
- **Lead sponsor:** Erbe Elektromedizin GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-27
- **Primary completion:** 2025-04-15
- **Final completion:** 2025-04-15
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-10-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05587491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05587491, "HybridAPC for Gastric Mucosal Ablation in Obese Patients.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05587491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*